TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
OACC

Oaktree Acquisition Corp. III Life Sciences

Financial Services · Shell Companies

10.80$ +0.0% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns Oaktree Acquisition Corp. III Life Sciences (OACC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 93.3% of the shares are freely tradable; institutional investors hold 88.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 88.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 93.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.01%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 20Mio.

Largest Shareholders

Institutions

Institutions OACC
Name Stake (%) Shares Change (%) Date
Cnh Partners, LLC 5.39 1,324,175 -6.3 03/31/2026
Decagon Asset Management LLP 4.08 1,002,427 +48.4 03/31/2026
Fort Baker Capital Management LP 4.07 1,000,000 +0.0 03/31/2026
Empyrean Capital Partners, LP 3.66 900,000 +0.0 06/30/2026
D. E. Shaw & Co LP 3.51 861,625 +0.0 06/30/2026
Boussard & Gavaudan Assets 2.93 720,000 +0.0 03/31/2026
Linden Advisors LLC 2.44 600,000 +0.0 06/30/2026
OZ Management LLC 2.16 530,807 +0.1 03/31/2026
The Goldman Sachs Group Inc 2.15 529,535 +0.0 03/31/2026
Moore Capital Management, LP 2.14 525,000 +0.0 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?